A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
Clinical trial NCT00502996 · COMPLETED
Trial details
- NCT number
- NCT00502996
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2008-12-01
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.